Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Australian biochemists trying to find out how smoke causes lung disease have targeted the role of a protein that is crucial ...

Broadway performers will sing show tunes at a fundraising event aimed at boosting awareness of pulmonary fibrosis.

The stars of Broadway will perform show tunes in the Pulmonary Fibrosis Foundation’s (PFF) 15th annual Broadway Belts for PFF ...

For the first time Australian researchers have identified how exposure to smoking may cause a deadly lung disease that claims ...

Oxygen is essential to life. The respiratory system works tirelessly to provide fresh oxygen to the body and ensure that all ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

A groundbreaking study led by researchers at Brock University has identified a potential cure for chronic lung diseases, such ...